Effect of latanoprost, prostaglandin F2α and nipradilol on isolated bovine ciliary muscle

Japanese Journal of Ophthalmology

Volumn 46, Issue 4, 2002, Pages 401-405

  Yoshitomi, Takeshi ^a   Yamaji, Kazutsuna ^a   Ishikawa, Hitoshi ^b   Ohnishi, Yoshitaka ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ciliary muscle; Latanoprost; Nipradilol; Prostaglandin F2; Uveoscleral outflow

Indexed keywords

ACETYLCHOLINE; LATANOPROST; NIPRADILOL; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTICLE; CATTLE; CILIARY MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE RELAXATION; MUSCLE TONE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CATTLE; CILIARY BODY; DINOPROST; ELECTRIC STIMULATION; ISOMETRIC CONTRACTION; MUSCLE, SMOOTH; PROPANOLAMINES; PROSTAGLANDINS F, SYNTHETIC;

EID: 0036661801     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(02)00531-2     Document Type: Article

References (28)

1. Alm A., Widengard I., Kjellgren D.et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 79:1995;12-16.
2. Camras C.B., Alm A., Watson P., Stjernschantz J. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology. 103:1996;1916-1924.
3. Mishima HK, Masuda K, Kitazawa Y, Azuma I, Araie M. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol 1996;114:929-932.
4. Suzuki M., Mishima H.K., Masuda K., Araie M., Kitazawa Y., Azuma I. Efficacy and safety of latanoprost eye drops for glaucoma treatment. a 1-year study in Japan Jpn J Ophthalmol. 44:2000;33-38.
5. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology. 100:1993;1297-1304.
6. Toris C.B., Camras C.B., Yablonski M.E., Brubaker R.F. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol. 41(Suppl 2):1997;S69-S75.
7. 2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 111:1993;1351-1358.
8. 2α Arch Ophthalmol. 105:1987;1112-1116.
9. 2α-isopropylester on anterior segment morphology. Prog Clin Biol Res. 312:1989;437-446.
10. 2α treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol. 117:1999;794-801.
11. Lindsey J.D., Kashiwagi K., Kashiwagi F., Weinreb R.N. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci. 38:1997;2214-2223.
12. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Exp Eye Res. 67:1998;179-191.
13. 2α effects on isolated rhesus monkey ciliary muscle. Invest Ophthalmol Vis Sci. 36:1995;2461-2465.
14. Suzuki R., Kobayashi S. Response of bovine intra-ocular muscles to transmural stimulation in the presence of various prostaglandins. Exp Eye Res. 36:1983;789-798.
15. 2α on porcine ciliary muscle cells in culture. Curr Eye Res. 14:1995;1155-1163.
16. Kanno M., Araie M., Koibuchi H., Masuda K. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans. Br J Ophthalmol. 84:2000;293-299.
17. Kanno M., Araie M., Tomita K., Sawanobori K. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation. Invest Ophthalmol Vis Sci. 39:1998;736-743.
18. Poyer J.F., Kaufman P.L., Flugel C. Age does not affect contractile responses of the isolated rhesus monkey ciliary muscle to muscarinic agonists. Curr Eye Res. 12:1993;413-422.
19. Yoshitomi T., Ito Y. Pre-synaptic actions of noradrenaline on the dog ciliary muscle tissue. Exp Eye Res. 43:1986;119-127.
20. Lograno M.D., Daniele E., Giovanazzi S., Guarrera A., Nicosia S. Effects of prostaglandins and PAF on the contractility of the bovine ciliary muscle. Pharmacol Res. 25:1992;195-202.
21. Krauss A.H., Wiederholt M., Sturm A., Woodward D.F. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp Eye Res. 64:1997;447-453.
22. Ito Y., Yoshitomi T. Membrane and contractile properties of the dog ciliary muscle. Br J Pharmacol. 88:1986;629-638.
23. Goh Y., Hotehama Y., Mishima H.K. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest Ophthalmol Vis Sci. 36:1995;1188-1192.
24. 2α on calcium efflux. Invest Ophthalmol Vis Sci. 33:1992;2679-2686.
25. Yousufzai S.Y., Zheng P., Abdel-Latif A.A. Muscarinic stimulation of arachidonic acid release and prostaglandin synthesis in bovine ciliary muscle. prostaglandins induce cyclic AMP formation and muscle relaxation Exp Eye Res. 58:1994;513-522.
26. 2α and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res. 63:1996;305-310.
27. Otsuka N., Yoshitomi T., Tsuchiya K., Ukai K., Ooki C., Ishikawa S. Effects of topical application of isopropyl unoprostone on refraction and accommodation. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 100:1996;531-534.
28. Stjernschantz J.W. From PGF2α-isopropyl ester to latanoprost. a review of the development of xalatan Invest Ophthalmol Vis Sci. 42:2001;1134-1145.